Monitor for unusual symptoms Pay attention to any changes in the 24-48 hours after injection
The underlying driver is chronic inflammationspecifically, dysregulated immune signaling involving TNF-, interleukins (IL-17, IL-23), and NF-B pathways
The necessary bridge from animal pharmacology to human safety and effectiveness has not been established
Discontinue if: Significant adverse reactions occur, you achieve body composition goals, no response after 8-12 weeks at optimal dosing, medical contraindications develop, or pregnancy occurs
It was developed in Russia and investigated for its potential regenerative effects in various tissues
Medication will almost always mention what product should be used to dilute it in the directions, and most will specify bacteriostatic sterile water for injection